Abstract:Objective: To observe the expression level of cytokines in patients with sepsis and its effect on prognosis. Methods: The clinical data of sepsis patients admitted to the intensive care unit (ICU) of the First Affiliated Hospital of Zhengzhou University from January 2020 to December 2022 were analyzed retrospectively, including gender, age, and acute physiology and chronic health evaluation II (APACHE II), blood routine, procalcitonin (PCT), C-reactive protein (CRP), and cytokines levels [interleukins (IL-2, IL-4, IL-6, IL-10, IL-17), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ)] within 24 hours of admission to ICU. The 28-day prognosis of the patients was followed up. The patients were divided into survival group and death group according to the prognosis. The clinical data between the two groups of sepsis patients with different prognosis were compared. Binary Logistic regression analysis was used to analyze the independent risk factors affecting the prognosis of patients with sepsis, and the receiver operator characteristic curve (ROC curve) was drawn to evaluate the predictive value of each risk factor for the prognosis of patients with sepsis. Results: (1) A total of 227 patients with sepsis were enrolled, including 168 patients in the survival group (survival rate 74.0%) and 59 patients in the death group (mortality 26.0%). There were no significant differences in age (years old: 55.97±2.13 vs. 54.67±1.11) and gender (male: 71.2% vs. 57.1%) between the death group and the survival group (both P > 0.05), indicating that the baseline data of the two groups were comparable. (2) The APACHE II (19.37±0.99 vs. 14.88±0.61, P < 0.001) and PCT (μg/L: 12.39±2.94 vs. 4.14±0.90, P < 0.001) in the death group were significantly higher than those in the survival group, while the platelet count [PLT (×109/L): 144.75±12.50 vs. 215.99±11.26, P = 0.001] and thrombocytocrit [(0.14±0.01)% vs. (0.19±0.01)%, P = 0.001] were significantly lower than those in the survival group. (3) The level of IL-6 in the death group was significantly higher than that in the survival group (ng/L: 577.66±143.16 vs. 99.74±33.84, P < 0.001). There were no statistically significant differences in other cytokines, IL-2, IL-4, IL-10, TNF-α, IFN-γ and IL-17 between the death group and the survival group [IL-2 (ng/L): 2.44±0.38 vs. 2.63±0.27, P = 0.708; IL-4 (ng/L): 3.26±0.67 vs. 3.18±0.34, P = 0.913; IL-10 (ng/L): 33.22±5.13 vs. 39.43±2.85, P = 0.262; TNF-α (ng/L): 59.33±19.21 vs. 48.79±29.87, P = 0.839; IFN-γ (ng/L): 6.69±5.18 vs. 1.81±0.16, P = 0.100; IL-17 (ng/L): 2.05±0.29 vs. 2.58±0.33, P = 0.369]. (4) Binary Logistic regression analysis showed that APACHE II and IL-6 were independent risk factors affecting the prognosis of patients with sepsis [odds ratio (OR) and 95% confidence interval (95%CI) were 1.050 (1.008-1.093) and 1.001 (1.000-1.002), P values were 0.019 and 0.026, respectively]. (5) ROC curve analysis showed that APACHE II and IL-6 had certain predictive value for the prognosis of patients with sepsis, the area under the ROC curve (AUC) was 0.754 (95%CI was 0.681-0.827) and 0.592 (95%CI was 0.511-0.673), P values were < 0.001 and 0.035, respectively. When the optimal cut-off value of APACHE II was 16.50 score, the sensitivity was 72.6% and the specificity was 69.9%. When the optimal cut-off value of IL-6 was 27.87 ng/L, the sensitivity was 67.2% and the specificity was 52.8%. Conclusions: APACHE II score and IL-6 level have certain predictive value for the prognosis of patients with sepsis, the higher APACHE II score and IL-6 level, the greater the probability of death in patients with sepsis.

Alterations in levels of cytokine following treatment to predict outcome of sepsis: A meta-analysis

Recent advances in the biology of IL-1 family cytokines and their potential roles in development of sepsis.

The associations between cytokine levels and clinical outcomes in critically ill patients after surgery: a retrospective cohort study

Association of the inflammation cytokine expression with clinical outcomes in critically ill patients after major surgery: A retrospective cohort study

1003. Cytokine Levels in Sepsis and TNFα Association with Mortality but not Sepsis Severity or Infection Source: a Systematic Review and Meta-analysis

Clinical significance of changes in cytokine levels in patients with severe abdominal infection

Postoperative cytokine levels and their predictive value in critical patients after major abdominal surgery: a retrospective cohort study

Changes in Early T-Cell Subsets and Their Impact on Prognosis in Patients with Sepsis: A Single-Center Retrospective Study

Proinflammatory Cytokine Levels in Sepsis and in Health and TNFÎ± Association with Sepsis Mortality and patient characteristics: a Systematic Review and Meta-analysis

[Expression level of cytokines in patients with sepsis and its effect on prognosis]

Elevations in presepsin, PCT, hs-CRP, and IL-6 levels predict mortality among septic patients in ICU

Differential expression of plasma cytokines in sepsis patients and their clinical implications

Dynamic changes of the serum pro-and anti-inflammatory cytokines and its significance in assessing clinical condition for sepsis patients

[Analysis of lymphocyte subsets in patients with sepsis and its impact on prognosis]

Impact of interleukin 6 levels on acute lung injury risk and disease severity in critically ill sepsis patients

The clinical importance of a cytokine network in the acute phase of sepsis

Dynamic Changes in Serum IL-6, IL-8, and IL-10 Predict the Outcome of ICU Patients with Severe COVID-19.

The Predictive Prognostic Values of Serum Interleukin-2, Interleukin-6, Interleukin-8, Tumor Necrosis Factor-Α, and Procalcitonin in Surgical Intensive Care Unit Patients.

Simplified immune-dysregulation index: A novel marker predicts 28-day mortality of intensive care patients with sepsis

Association Between Changes in Plasma Metabolism and Clinical Outcomes of Sepsis.

Correlation analysis of systemic immune inflammatory index, Serum IL-35 and HMGB-1 with the severity and prognosis of sepsis